Extra-corporeal membrane oxygenation (ECMO) is primarily used to provide cardiopulmonary support. Extracorporeal membrane oxygenation (ECMO) is a lifesaving technique used in critically ill patients presenting acute cardiac and/or pulmonary dysfunctions, who are at high risk of developing acute kidney injury (AKI) and fluid overload (FO).Read More.
Dyspepsia involves at least one of the cases of belly dysfunction after meals, early onset satiety when a person eats a normal meal, and epigastric pain or burning sensation. The aim of this study was to investigate endoscopic and pathological findings in patients referred to Imam Khomeini Hospital in Urmia, Iran.Read More.
SOURCE. www.cdc.gov Authors. Shikha Garg, MD1,*; Lindsay Kim, MD1,*; Michael Whitaker, MPH1,2; Alissa O’Halloran, MSPH1; Charisse Cummings, MPH1,3; Rachel Holstein, MPH1,4; […]Read More.
This review addresses the magnitude of the problem of diabetes, prevalence and cardiovascular complications of DM in the Gulf Cooperation Council (GCC) countries. Further, the review also highlights the causes, guideline implications, and prevention measures for DM control in the GCC countries.Read More.
The current review aims to highlight the role of frailty in patient selection for TAVR, prognostication, and tailoring post-operative care to enhance quality of life.Read More.
We aimed to find the association between baseline coronary patency & culprit site with PCI outcome and the incidence of major adverse cardiac events (MACE).Read More.
The aim of this study is to investigate the association of CHA2DS2-VASc-HSF score with severity of Coronary Artery Disease as assessed by Syntax Score (SxS) in patients with Non ST Segment Elevation Myocardial Infarction.Read More.
Evidence-based practice (EBP) is an integral part of stroke rehabilitation, to achieve optimal results by practicing best evidence available in the literature. A survey was conducted to find the knowledge of EBP and preferred treatment used by the physiotherapists in Saudi Arabia for stroke rehabilitation.Read More.
Cancer therapies can affect the whole cardiovascular system, but these cardiotoxic effects are generally reported as changes in left ventricular (LV) ejection fraction. The most common cardiovascular adverse effects are LV dysfunction and heart failure (HF). Other adverse effects include hypertension, acute coronary syndromes, thromboembolic events, rhythm disturbances, and valvular and/or pericardial disease. Hence, prediction, early recognition, and timely management of cardiovascular complications in patients with cancer are gaining importance. This need gave birth to the concept of interdisciplinary cardiology-oncology (cardio-oncology) care delivered through teams of cardiologists, oncologists, and hematologists.Read More.
Abstract Residual cardiovascular risk despite intensive statin therapy necessitates additional management in patients with dyslipidemia. Icosapent, an ethyl ester of […]Read More.